Literature DB >> 19088796

Effect of oxidative stress on the expression of t-PA, u-PA, u-PAR, and PAI-1 in endothelial cells.

Katarzyna Oszajca1, Magdalena Bieniasz, George Brown, Maria Swiatkowska, Jacek Bartkowiak, Janusz Szemraj.   

Abstract

In this study we examined the effects of exogenous nitric oxide (sodium nitroprusside, SNP) and hydrogen peroxide (H2O2) on the expression level of tissue-type plasminogen activator (t-PA), urokinase-type plasminogen activator (u-PA), urokinase-type plasminogen activator receptor (u-PAR), and plasminogen activator inhibitor type 1 (PAI-1) in human umbilical vein endothelial cells (HUVEC). The expression of selected genes involved in fibrynolysis under the influence of oxidative stress was analyzed at the levels of mRNA, protein, and promoter activity. The results of the conducted studies revealed that oxidative stress in endothelial cells causes a significant increase in PAI-1 and u-PAR expression and a moderate increase in t-PA and u-PA expression at all of the investigated levels. We attempted to elucidate the molecular signaling mechanisms by which SNP and H2O2 regulate expression of the respective fibrinolytic factors. Therefore, we tested the protein levels of AP-1, NF-kappaB, and HIF-1 and their DNA-binding activity in endothelial cells subjected to oxidative stress. We found strong correlation between AP-1, NF-kappaB, and HIF-1 in the contribution of regulation of selected genes. In addition, we also found that the inhibition of PAI-1 synthesis by antisense oligonucleotide to PAI-1 mRNA results in markedly increased u-PAR expression and that NF-kappaB and AP-1 are involved in this regulation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19088796     DOI: 10.1139/O08-137

Source DB:  PubMed          Journal:  Biochem Cell Biol        ISSN: 0829-8211            Impact factor:   3.626


  7 in total

1.  Stress-induced PAI-1 expression is suppressed by pitavastatin in vivo.

Authors:  Koji Yamamoto; Kyosuke Takeshita; Tetsuhito Kojima; Junki Takamatsu
Journal:  Int J Hematol       Date:  2009-04-08       Impact factor: 2.490

2.  Plasminogen activator inhibitor 1, fibroblast apoptosis resistance, and aging-related susceptibility to lung fibrosis.

Authors:  Wen-Tan Huang; Hasina Akhter; Chunsun Jiang; Mark MacEwen; Qiang Ding; Veena Antony; Victor John Thannickal; Rui-Ming Liu
Journal:  Exp Gerontol       Date:  2014-11-28       Impact factor: 4.032

3.  Synaptic protein expression is regulated by a pro-oxidant diet in APPxPS1 mice.

Authors:  Martin Broadstock; Rikke Lewinsky; Emma L Jones; Cathy Mitchelmore; David R Howlett; Paul T Francis
Journal:  J Neural Transm (Vienna)       Date:  2011-11-05       Impact factor: 3.575

4.  Regulation of plasminogen activator inhibitor-1 expression in endothelial cells with exposure to metal nanoparticles.

Authors:  Min Yu; Yiqun Mo; Rong Wan; Sufan Chien; Xing Zhang; Qunwei Zhang
Journal:  Toxicol Lett       Date:  2010-02-18       Impact factor: 4.372

Review 5.  PAI-1: A Major Player in the Vascular Dysfunction in Obstructive Sleep Apnea?

Authors:  Mohammad Badran; David Gozal
Journal:  Int J Mol Sci       Date:  2022-05-15       Impact factor: 6.208

6.  Inhibitory effects of Kaempferia parviflora extract on monocyte adhesion and cellular reactive oxygen species production in human umbilical vein endothelial cells.

Authors:  Satoru Horigome; Izumi Yoshida; Shihomi Ito; Shuichi Inohana; Kei Fushimi; Takeshi Nagai; Akihiro Yamaguchi; Kazuhiro Fujita; Toshiya Satoyama; Shin-Ichi Katsuda; Shinobu Suzuki; Masatoshi Watai; Naoto Hirose; Takahiro Mitsue; Hitoshi Shirakawa; Michio Komai
Journal:  Eur J Nutr       Date:  2015-12-24       Impact factor: 5.614

7.  Angiotensin-converting enzyme inhibitors attenuate propofol-induced pro-oxidative and antifibrinolytic effect in human endothelial cells.

Authors:  Marzena Wojewodzka-Zelezniakowicz; Anna Gromotowicz-Poplawska; Wioleta Kisiel; Emilia Konarzewska; Janusz Szemraj; Jerzy Robert Ladny; Ewa Chabielska
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2017-01       Impact factor: 1.636

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.